What question did this study set out to answer?

To assess long-term changes in incidence, survival, and mortality rates of cutaneous malignant melanoma in Scotland between 1979 and 1994.

November 1, 1997BMJOpen Access

Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94

View Full Paper

Ask AI

Bookmark

Authors

RMR.M. MACKIERoyal Society DHD. HoleChristiana Care Health System JHJohn HunterQueen's University Belfast

Discussion

Member takes

Implication

Population registry analysis reveals rising melanoma incidence in men but plateauing rates and improved survival in women, highlighting persistent sex disparities in disease outcomes.

Key Points

To assess long-term changes in incidence, survival, and mortality rates of cutaneous malignant melanoma in Scotland between 1979 and 1994.
Population-based registry analysis of 6,288 patients diagnosed with primary invasive cutaneous malignant melanoma from January 1, 1979, to December 31, 1994.
Comprehensive evaluation of clinical and pathological characteristics, therapeutic interventions, and follow-up data from a specialized Scottish database.
Annual age-standardized incidence increased significantly from 3.5 to 7.8 per 100,000 per year in men and from 6.8 to 12.3 per 100,000 per year in women (P<0.001 for both), with female rates stabilizing after 1986.
Mortality increased significantly in men from 1.3 to 2.3 per million per year (P<0.01) but showed a non-significant decrease in women from 2.4 to 1.9 per million per year (P=0.09).
Five-year melanoma-free survival was 69% in men versus 82% in women, with 5-year survival remaining strongly linked to tumour thickness (96% in women and 91% in men for <1.5 mm vs. 54% in women and 42% in men for >3.5 mm).

Cite This Study

MACKIE et al. (1997) studied this question.

synapsesocial.com/papers/6a7fa2a55a7e1563e018f306 https://doi.org/10.1136/bmj.315.7116.1117

View Full Paper

Ask AI

Bookmark

Implication

Population registry analysis reveals rising melanoma incidence in men but plateauing rates and improved survival in women, highlighting persistent sex disparities in disease outcomes.

Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94

Discussion

Member takes

Implication

Key Points

Cite This Study

Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider